SCHEMBL21646767

SCHEMBL21646767

CC1CCc2cc3c(c(OC#N)c21)CCC3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25515114 1.00 — —
SCHEMBL25507986 0.87 — —
SCHEMBL19869343 0.83 NLRP3 (0.32) —
SCHEMBL21646764 0.80 NLRP3 (0.30) —
SCHEMBL25507493 0.73 — —
SCHEMBL21646756 0.72 — —
SCHEMBL23674551 0.72 BCHE (0.32) —
SCHEMBL20692050 0.72 BCHE (0.32) —
SCHEMBL21646540 0.72 NLRP3 (0.32) —
SCHEMBL30041743 0.72 BCHE (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253596-A1 SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY GENENTECH, INC. (US) 2021-08-19 — — US disclosed
WO-2020018975-A1 SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY GENENTECH, INC. (US) 2020-01-23 — — WO disclosed
Send feedback